Trade GKOS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Glaukos Corporation (GKOS) is trading at US$182.29, up 0.21% today as of Aug 28, 09:45 EDT. The company has a market capitalisation of US$10.91B. Over the past 52 weeks, GKOS has traded between US$73.16 and US$191.62. On Syfe you can trade GKOS with $0 commission and add it to your watchlist.
| Previous close | US$181.91 |
|---|---|
| Market cap | US$10.91B |
| P/E ratio | 804.07 |
| 52-week range | US$73.16 – US$191.62 |
| Volume | 442.29K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Glaukos Corporation
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard A. Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.
Year: 2015
Glaukos Corporation (GKOS) stock is trading at US$182.29, +0.21% from the previous close of US$181.91.
The market cap for Glaukos Corporation (GKOS) stock is approximately US$10.91B.
The price-to-earnings ratio for Glaukos Corporation (GKOS) is 804.07, based on the latest reported earnings.
The 52-week high for Glaukos Corporation (GKOS) stock is US$191.62.
The 52-week low for Glaukos Corporation (GKOS) stock is US$73.16.
Glaukos Corporation (GKOS) does not currently pay a dividend.
Stay on top of GKOS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
